BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18485459)

  • 1. Long-term survival in bilateral renal cell carcinoma: a retrospective single-institutional analysis of 101 patients after surgical treatment.
    Becker F; Siemer S; Tzavaras A; Suttmann H; Stoeckle M
    Urology; 2008 Aug; 72(2):349-53. PubMed ID: 18485459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
    Takagi T; Kondo T; Izuka J; Kobayashi H; Tomita E; Hashimoto Y; Tanabe K
    Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
    Krambeck A; Iwaszko M; Leibovich B; Cheville J; Frank I; Blute M
    BJU Int; 2008 Jun; 101(11):1375-9. PubMed ID: 18454793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
    Klatte T; Wunderlich H; Patard JJ; Kleid MD; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
    BJU Int; 2007 Jul; 100(1):21-5. PubMed ID: 17433034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
    Klatte T; Patard JJ; Wunderlich H; Goel RH; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
    J Urol; 2007 Jun; 177(6):2081-6; discussion 2086-7. PubMed ID: 17509291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
    Blute ML; Amling CL; Bryant SC; Zincke H
    Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients.
    Amano H; Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Shimada K; Nakazawa H; Ito F; Tanabe K
    Int J Urol; 2010 Jul; 17(7):615-22. PubMed ID: 20482658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
    Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
    BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
    Minervini A; Serni S; Giubilei G; Lanzi F; Vittori G; Lapini A; Carini M
    Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
    Ficarra V; Novara G; Galfano A; Novella G; Schiavone D; Artibani W
    Urology; 2004 Jun; 63(6):1050-4. PubMed ID: 15183948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.